INHBA and cervical carcinoma: The results demonstrated that higher INHBA expression was associated with poorer prognosis for OS (p = 0.001, HR = 2.30, 95% CI: 1.41–3.76) (Figure 6A), DSS (p = 0.006, HR = 2.18, 95% CI: 1.25–3.81) (Figure 6B), and PFI (p = 0.001, HR = 2.26, 95% CI: 1.39–3.67) (Figure 6C) in cervical cancer.